Fingolimod-induced asthma deterioration in a patient with relapsing

Abstract

Get full access to this article

View all access options for this article.

References

Kappos

Radue

O’Connor

. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N Engl J Med 2010; 362: 387–401.

Kappos

Antel

Comi

. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med 2006; 355: 1124–1140.

Trifilieff

Fozard

Sphingosine-1-phosphate-induced airway hyper-reactivity in rodents is mediated by the sphingosine-1-phosphate type 3 receptor. J Pharmacol Exp Ther 2012; 342: 399–406.

Voldsgaard

Koch-Henriksen

Magyari

. Cardiac and pulmonary effects related to initiation of fingolimod treatment. (Oct 4, 2013).

Slade

. Effects of oral fingolimod (FTY720) on pulmonary function tests in patients with moderate asthma. Neurology 2010; 74(number 9, supplement 2).

Fingolimod-induced asthma deterioration in a patient with relapsing–remitting multiple sclerosis

Abstract

Get full access to this article

References